Bridging the Gap: How Bracken Supports Biotech and Pharma Companies Using Imaging Endpoints in Clinical Trials

The Scenario

As the use of imaging endpoints in clinical trials has increased steadily over the last 30 years, an imaging core lab (ICL) — or sometimes called an imaging CRO — is often involved.

Sponsors using imaging endpoints in clinical trials are often dependent on ICLs they lack the expertise to oversee. That knowledge gap creates real risk: inadequate oversight of ICLs can lead to data quality failures, protocol misalignment, and costly delays....  

Bracken's imaging experts bridge that gap: protecting data integrity, timelines, and submissions.